title: Benzodiazepine use in older adults enrolled in a health maintenance organization.
abstract: OBJECTIVE
  The authors examined patterns of benzodiazepine use in older adults. Specifically, they describe prevalence and incidence of benzodiazepine use during the index year, describe persistence and intensity of benzodiazepine use over a 4-year period; and examine factors associated with benzodiazepine use in the upcoming year.
  
  
  METHODS
  Authors performed a secondary analysis of data collected as part of a health promotion intervention trial conducted from 1986 to 1992 in older health maintenance organization enrollees (N=1,505). Benzodiazepine use was ascertained from computerized pharmacy records. Demographic characteristics, health status, and health behaviors were ascertained from mailed questionnaires.
  
  
  RESULTS
  During the index year, the prevalence and incidence of benzodiazepine use was 12.3% and 6.6%, respectively. Of those using during the index year, 16% of new users and 63% of previous users continued to use for the following 3 years. The factors significantly associated with benzodiazepine use in the following year were female gender, high school education, higher chronic disease score, higher levels of self-reported pain and stress, low-to-normal body mass index (BMI), and self-reported nervous disorder.
  
  
  CONCLUSIONS
  New users had low intensity of use and a low probability of continuing use over the following 3 years. A very small percentage of this sample had evidence of daily use for 4 years. Of concern, benzodiazepines were used by the segment of the sample that were at greatest risk for hip fractures (women with normal/low BMI). Clinicians should assess the need for continued benzodiazepine use at regular intervals.
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001569:Benzodiazepines / Q000627:therapeutic use*; D017723:Drug Utilization Review; D005260:Female; D006279:Health Maintenance Organizations / Q000706:statistics & numerical data*; D006620:Hip Fractures / Q000150:complications* / Q000453:epidemiology; D006801:Humans; D008297:Male; D010146:Pain / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology*
chemical_list: D001569:Benzodiazepines